Waters provides workflow solutions in liquid chromatography, mass spectrometry, and thermal analysis, employing 7,900 people in Milford, Massachusetts. Its segments include Waters and TA, focusing on chromatography and thermal analysis instruments.
Based on our analysis, Waters Corporation has received an overvalued rating of 2 out of 5 stars. Several key financial ratios indicate that the company's valuation may not be justified when compared to its sector peers.
The Price-to-Earnings (PE) ratio for Waters stands at 32.69, significantly higher than the sector average of 13.90. A higher PE ratio suggests that investors are paying more for each dollar of earnings, which can indicate overvaluation if not supported by corresponding growth in earnings.
Similarly, the Price-to-Book (PB) ratio is 12.05, compared to the sector's 2.64. The PB ratio measures the market's valuation of a company's equity relative to its book value. A high PB ratio can imply that investors expect high growth, but without strong earnings growth to support this expectation, it may indicate that Waters is overvalued.
Additionally, while Waters boasts a strong net profit margin of 21.56, the sector average is a negative -138.43, suggesting that profitability is not the main concern. However, the company's exceptional margins do not justify the high valuation ratios.
In terms of returns, the Return on Equity (ROE) for Waters is 34.88, which is favorable compared to the sector’s -75.69. However, this high return may not be sustainable given the elevated valuation metrics, indicating potential risk for investors.
This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Health Care
Overvalued
More Signals
Feature in Progress
This section is under development. Check back soon for updates!